The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
Over the past decades, adoptive transfer of T cells has revolutionized cancer immunotherapy. In particular, T-cell receptor (TCR) engineering of T cells has marked important milestones in developing more precise and personalized cancer immunotherapies. However, to get the most benefit out of this ap...
Main Authors: | Diana Campillo-Davo, Donovan Flumens, Eva Lion |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1720 |
Similar Items
-
Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity
by: Hye-Ran Kim, et al.
Published: (2021-02-01) -
Identifying individual T cell receptors of optimal avidity for tumor antigens
by: Michaël eHebeisen, et al.
Published: (2015-11-01) -
Regulation of T Helper Cell Fate by TCR Signal Strength
by: Nayan D. Bhattacharyya, et al.
Published: (2020-05-01) -
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
by: Minh Ngoc Duong, et al.
Published: (2019-11-01) -
Human γδ TCR Repertoires in Health and Disease
by: Alina Suzann Fichtner, et al.
Published: (2020-03-01)